Viking Therapeutics Inc — Quarterly Cash Flow (NASDAQ:VKTX) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 937.89 M908.32 M866.99 M827.85 M739.41 M715.73 M Total liabilities 26.44 M28.04 M20.07 M32.39 M26.39 M76.67 M Total equity 911.45 M880.28 M846.92 M795.46 M713.03 M639.06 M Total liabilities & shareholders' equities 937.89 M908.32 M866.99 M827.85 M739.41 M715.73 M Total debt —————— Net debt ——————

新闻

Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead?

Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026

American Express, Oracle among market cap stock movers on Monday

Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin

Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough? (GPCR)

Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition?

Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk

NVO Crashes 21% in a Month: Is This an Indication to Sell the Stock?

Viking Therapeutics: Full-Speed Ahead (NASDAQ:VKTX)

Viking: Buyers Quietly Accumulating On Obesity Drugs Launch Potential (NASDAQ:VKTX)

Cisco and Micron among market cap stock movers on Thursday

How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report